Medindia

X

Chem Rx Corporation to Report Second Quarter 2008 Financial Results

Tuesday, August 12, 2008 General News J E 4
Advertisement
LONG BEACH, N.Y., Aug. 12 Chem Rx Corporation(OTC Bulletin Board: CHRX, CHRXU, CHRXW), a leading provider of institutionalpharmacy services, announced today that it will hold a conference call toreview its second quarter 2008 results on August 14, 2008 at 8:30 a.m. ET.Jerry Silva, Chairman and Chief Executive Officer, Steven C. Silva, Presidentand Chief Operating Officer, and Gary M. Jacobs, Chief Financial Officer willhost the conference call. A press release announcing second quarter 2008results will be issued on August 14, 2008, before the market open.

To participate in the conference call, please dial 1-877-407-0784 (USA) or1-201-689-8560 (international). In addition, a dial-up replay of theconference call will be available beginning August 14, 2008 at approximately11:30 a.m. ET and will remain available until August 21, 2008. To access thereplay, please dial 1-877-660-6853 (USA) or 1-201-612-7415 (international) andreference the account number 3055 and the access code 293126. A web cast ofthe call will also be available from the Investor Relations section on thecorporate web site at http://www.chemrx.net through September 14, 2008.

About Chem Rx Corporation

Founded more than 40 years ago, Chem Rx is a major institutional pharmacyserving the New York City metropolitan area, as well as parts of New Jersey,upstate New York, Pennsylvania and Florida. Chem Rx's client base includesskilled nursing facilities and a wide range of other long-term carefacilities. Chem Rx annually provides over six million prescriptions to morethan 67,000 residents of more than 440 institutional facilities. Chem Rx'swebsite address is www.chemrx.net.

Forward Looking Statements

This press release contains forward-looking statements within the meaningof the Private Securities Litigation Reform Act of 1995. Forward-lookingstatements are statements that are not historical facts. Such forward-lookingstatements are based upon the current beliefs and expectations of Chem Rx'smanagement and are subject to risks and uncertainties that could cause actualresults to differ from the forward-looking statements. The following factors,among others, could cause actual results to differ from those set forth in theforward-looking statements: compliance with government regulations; changesin legislation or regulatory environments; requirements or changes adverselyaffecting the health care industry, including changes in Medicarereimbursement policies; fluctuations in customer demand; management of rapidgrowth; intensity of competition; timing, approval and market acceptance ofnew product introductions and institutional pharmacy locations; generaleconomic conditions; geopolitical events and regulatory changes, as well asother relevant risks detailed in Chem Rx's filings with the Securities andExchange Commission. The information set forth herein should be read in lightof such risks. Chem Rx Corporation does not assume any obligation to updatethe information contained in this press release.Contacts: Gary M. Jacobs Chief Financial Officer Chem Rx Corporation 516-889-8770 The Ruth Group Investor Relations Stephanie Carrington / Jared Hoffman (646) 536-7017 / 7013 scarrington@theruthgroup.com jhoffman@theruthgroup.com

SOURCE Chem Rx Corporation
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
AlphaRx Receives Conditional Approval to List on t...
S
Swissray Selected by Adventist Health System to be...